Navigation Links
AcelRx Pharmaceuticals Reports Positive Results From a Phase 2 Clinical Trial of Sublingual Sufentanil NanoTabs(TM) in Treating Post-Operative Pain
Date:12/9/2008

REDWOOD CITY, Calif., Dec. 9 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. today announced positive results from a Phase 2 clinical study evaluating the safety and efficacy of its lead product candidate, ARX-01, for the treatment of moderate-to-severe inpatient acute pain following knee replacement surgery. The primary endpoint evaluated pain intensity (Sum of the Pain Intensity Difference - SPID12) over the 12-hour study period compared to baseline. Results demonstrated that compared to placebo, patients receiving 15 mcg of ARX-01 experienced a statistically significant reduction in pain intensity over the study period, based on the worst observation carried forward imputation method (WOCF), p=0.015. Additionally, at the 15 mcg dose, the study met an important secondary endpoint compared to placebo, the percentage of patient dropouts due to inadequate analgesia, p=0.006. Further, no serious or unexpected adverse events related to ARX-01 were reported in the study.

ARX-01 is a sublingual formulation of the opioid pain medication, sufentanil. ARX-01 is based on the company's proprietary NanoTab(TM) dosage form, which enables delivery of sufentanil by the non-invasive oral transmucosal (sublingual) route.

"We chose a very painful surgery in an elderly patient population to showcase the efficacy and safety of Sublingual Sufentanil NanoTabs in treating acute post-operative pain," said Pamela Palmer, M.D., Ph.D., chief medical officer of AcelRx Pharmaceuticals. "The superior attributes of both the drug and the dosage form enabled these highly encouraging Phase 2 results."

This multicenter, double-blind, randomized, placebo-controlled, dose-finding Phase 2 study evaluated the safety and efficacy of ARX-01 in patients undergoing elective unilateral knee replacement surgery. In the study, 101 patients were randomized to receive either placebo or one of three different dosage strengths of ARX-01: 5mcg, 10m
'/>"/>

SOURCE AcelRx Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
2. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
4. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
5. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
6. Nabi Biopharmaceuticals to Present at Upcoming Industry Conferences
7. Anadys Pharmaceuticals Appoints Steve Worland, Ph.D. as President and Chief Executive Officer
8. Poniard Pharmaceuticals Announces Participation in Upcoming Conferences
9. NovaQuest Advances Virtual Development Model With Strategic Investment in TOPIGEN Pharmaceuticals
10. Drug Royalty Corporation (DRC) Announces Acquisition Regarding PEG-INTRON(R) From Enzon Pharmaceuticals, Inc. (ENZN)
11. Sunesis Pharmaceuticals Announces Reorganization to Focus Resources and Build Value in Clinical-Stage Programs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... , June 2, 2015 /CNW/ - Shell today celebrated the ... the premium category with an exhibit the size of ... included interactive demonstrations for media and the public, and ... V-Power NiTRO+ Premium Gasoline provides the best total engine ... performance: engine wear, gunk and corrosion. "With ...
(Date:6/2/2015)... DUBLIN , June 02, 2015 Research ... of the "Bioburden Testing Market by Product , ... report to their offering. The bioburden ... 2019 from $354.4 Million in 2014, growing at a ... the basis of products, the microbial limit testing market ...
(Date:6/2/2015)... DUBLIN , June 02, 2015 ... addition of Jain PharmaBiotech,s new report "Biomarkers ... offering. This report follows the broad ... can be objectively measured and evaluated as an ... well as pharmacological responses to a therapeutic intervention. ...
(Date:6/2/2015)... Calif. (PRWEB) June 02, 2015 ... build-to-order, independent blade-based and rackmount computing and storage ... announced the launch of its high density scale-out, ... Cirrascale Slipstream™ RM1622D . The high density, ... E3-1200 v4 product family with Intel® Iris™ Pro ...
Breaking Biology Technology:New Shell V-Power NiTRO+ Premium Gasoline Introduces Breakthrough Formulation for BEST TOTAL Engine Protection 2New Shell V-Power NiTRO+ Premium Gasoline Introduces Breakthrough Formulation for BEST TOTAL Engine Protection 3New Shell V-Power NiTRO+ Premium Gasoline Introduces Breakthrough Formulation for BEST TOTAL Engine Protection 4Bioburden Testing Market 2015 - Global Forecasts to 2019 2Global Biomarkers Market Report 2015 - Technologies, Markets and Companies Analysis and Forecasts 2014-2024 2Global Biomarkers Market Report 2015 - Technologies, Markets and Companies Analysis and Forecasts 2014-2024 3Cirrascale® Announces Support for Intel® Xeon® Processor E3-1200 v4 Product Family; Launches Server Offering Optimized for Low Cost-per-Stream Transcoding Applications 2Cirrascale® Announces Support for Intel® Xeon® Processor E3-1200 v4 Product Family; Launches Server Offering Optimized for Low Cost-per-Stream Transcoding Applications 3
... - Company Achieves Record First Quarter of Net Product Sales; ... Cinryze(TM) C1 Esterase Inhibitor (Human) -EXTON, Pa., April 29 ... financial results for the first quarter ended March 31, 2009., ... First quarter 2009 adjusted net income of $11.5 million, ...
... provides grant to develop blood-based, ... nasopharyngeal, cancer -,TORONTO, April 29 ... focused on developing blood-based biomarker tests for the ... today announced that it will undertake a two-year ...
... 29 , - ... Elsevier, the world,s leading publisher ... announced today that ten new eBook,Specialty Collections have ... clinical reference tool. This launch provides online availability,of ...
Cached Biology Technology:ViroPharma Incorporated Reports First Quarter 2009 Financial Results 2ViroPharma Incorporated Reports First Quarter 2009 Financial Results 3ViroPharma Incorporated Reports First Quarter 2009 Financial Results 4ViroPharma Incorporated Reports First Quarter 2009 Financial Results 5ViroPharma Incorporated Reports First Quarter 2009 Financial Results 6ViroPharma Incorporated Reports First Quarter 2009 Financial Results 7ViroPharma Incorporated Reports First Quarter 2009 Financial Results 8ViroPharma Incorporated Reports First Quarter 2009 Financial Results 9ViroPharma Incorporated Reports First Quarter 2009 Financial Results 10ViroPharma Incorporated Reports First Quarter 2009 Financial Results 11ViroPharma Incorporated Reports First Quarter 2009 Financial Results 12ViroPharma Incorporated Reports First Quarter 2009 Financial Results 13ViroPharma Incorporated Reports First Quarter 2009 Financial Results 14ViroPharma Incorporated Reports First Quarter 2009 Financial Results 15GeneNews to conduct joint project funded by MYR 5 million grant from Malaysian government 2Elsevier Launches Ten New eBook Specialty Collections on MD Consult 2Elsevier Launches Ten New eBook Specialty Collections on MD Consult 3
(Date:4/27/2015)... 2015 Profile Solutions, Inc. (OTC: PSIQ), a ... is pleased to announce that Dr Gerry Bedore ... member of its scientific advisory board. ... thought leader in technology-enhanced learning models. He was a ... published studies and books focused on online student success ...
(Date:4/20/2015)... The announcement comes as demand for fire vault ... Ireland,s foremost records management company, has secured ... impressive track record of clients within the first 12 months, ... sector in Dubai . As a result, ... a further eight staff members at its Irish headquarters. The ...
(Date:4/14/2015)... April 14, 2015 NXT-ID, Inc. (NASDAQ: ... company focused on the growing mobile commerce market, announces ... the 2015 New York Design Awards under the category  ... York City Design Awards are part of a global ... 2,500 ratings from the marketplace, industry and judging panel. ...
Breaking Biology News(10 mins):Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 2Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 3Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 4Glenbeigh Records Management Wins Contract With Dubai Islamic Bank 2Glenbeigh Records Management Wins Contract With Dubai Islamic Bank 3NXT-ID's Wocket Smart Wallet Nominated for 2015 New York Design Awards in 'Product Design- Technology' 2NXT-ID's Wocket Smart Wallet Nominated for 2015 New York Design Awards in 'Product Design- Technology' 3
... method for fighting skin wrinkles has been developed at ... Quality Sciences. In her doctoral research at the ... antioxidant that delays the aging process by countering the ... conducted her research under the supervision of Zecharia ...
... of the most basic features of a living organism. ... in turn control others genes whose activity turns on ... cycle, energy production, DNA repair, cellular suicide etc). Many ... special proteins (transcription factors) to 6 - 10 nucleotide ...
... Smoking tobacco is no longer considered sexy, but it may prove ... the online open access journal BMC Genomics could help explain why ... who have never smoked. A Canadian team led by ... took samples from the lungs of 24 current and former smokers, ...
Cached Biology News:Antioxidant to retard wrinkles discovered by Hebrew University researcher 2Gene regulation in humans is closer than expected to simple organisms 2Smoking turns on genes -- permanently 2